{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443395571
| IUPAC_name = 5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
| image = Aprobarbital Structural Formulae.svg
| image2 = Aprobarbital ball-and-stick animation.gif
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|aprobarbital}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule IV
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 77-02-1
| ATC_prefix = N05
| ATC_suffix = CA05
| PubChem = 6464
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01352
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 6221
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q0YKG9L6RF
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00698
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 2791
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 7863
<!--Chemical data-->
| C=10 | H=14
| N=2 | O=3
| molecular_weight = 210.23 g/mol
| smiles = O=C1NC(=O)NC(=O)C1(C(C)C)C\C=C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UORJNBVJVRLXMQ-UHFFFAOYSA-N
| synonyms = aprobarbital, Oramon, allylpropymal, Alurate, 5-isopropyl- 5-allylbarbituric acid
}}

'''Aprobarbital''' (as known in the [[United States]], or '''aprobarbitone''' (as known elsewhere), sold as '''Oramon''', '''Somnifaine''', and '''Allonal''', is a [[barbiturate]] derivative invented in the 1920s by Ernst Preiswerk. It has [[sedative]], [[hypnotic]] and [[anticonvulsant]] properties, and was used primarily for the treatment of [[insomnia]].<ref> Reddemann H, Turk E. Oramon poisoning in infancy and childhood. Observations on 12 aprobarbital poisonings (German). Das Deutsche Gesundheitswesen. 1966 May 12;21(19):878-81. </ref>  Aprobarbital was never as widely used as more common barbiturate derivatives such as [[phenobarbital]] and is now rarely prescribed as it has been replaced by newer drugs with a better safety margin.

See also: [[Alphenal]]
== References ==
{{reflist}}

{{Barbiturates}}
{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Barbiturates]]
[[Category:Allyl compounds]]
[[Category:GABAA receptor positive allosteric modulators]]


{{sedative-stub}}